The Coca-Cola Company. Just Coke it!
Updated
Coca-Cola (KO) will likely post "solid" Q2 results next week as it benefits from "best in-class" organic growth, UBS said in an earnings preview emailed Tuesday.
The firm said it expected the company to book $0.79 in Q2 earnings per share.
UBS also expects the company to follow its recent historical pattern of increasing organic revenue and EPS growth guidance after it posts its Q2 results.
The firm said it expects Coca-Cola to achieve 8.9% in organic revenue growth, in line with consensus and at the high end of the company's guidance of 8% to 9%.
UBS added that it does not think the "bar has shifted" for the company in the context of a more challenged Q2 for rival PepsiCo (PEP) . Instead, the firm said that global beverage volume performance and pricing in North America were either in line or better than expected.
UBS has a buy rating on the company's stock with a price target of $74.
Consumer staples Go higher, break up 52-weeks highs
In fundamental terms, The Coca-Cola likely will be benefited by lower interest rates, while in technical terms it has just set new 52-weeks highs.
In long-term Coca-Cola shares follow above 5-years SMA for a 15th consecutive year in a row.
The firm said it expected the company to book $0.79 in Q2 earnings per share.
UBS also expects the company to follow its recent historical pattern of increasing organic revenue and EPS growth guidance after it posts its Q2 results.
The firm said it expects Coca-Cola to achieve 8.9% in organic revenue growth, in line with consensus and at the high end of the company's guidance of 8% to 9%.
UBS added that it does not think the "bar has shifted" for the company in the context of a more challenged Q2 for rival PepsiCo (PEP) . Instead, the firm said that global beverage volume performance and pricing in North America were either in line or better than expected.
UBS has a buy rating on the company's stock with a price target of $74.
Consumer staples Go higher, break up 52-weeks highs
In fundamental terms, The Coca-Cola likely will be benefited by lower interest rates, while in technical terms it has just set new 52-weeks highs.
In long-term Coca-Cola shares follow above 5-years SMA for a 15th consecutive year in a row.
Trade active
July 24, 2024The Coca-Cola Company (KO) shares are trading higher following better-than-expected second-quarter FY24 earnings and a raised outlook.
The company reported second-quarter FY24 sales growth of 3% year-on-year to $12.4 billion, beating the analyst consensus estimate of $11.753 billion.
Revenue performance included a 6% climb in concentrate sales and a 9% growth in price/mix. Unit case volume grew 2% in the quarter. Organic revenues increased 15%.
Coca-Cola’s organic revenue in Europe, Middle East and Africa jumped 30% in the second quarter, while in North America, it increased 10%.
Trade active
July 30, 2024👉 The Coca-Cola stocks just printed new all the time high, rallying 10th consecutive month in a row.
👉 Wherever your trip, drink Coca-Cola.
Trade active
Aug 1, 2024👉 The Coca-Cola stocks continue to rise, jumping higher on 11th consecutive month in a row, despite of big tech sluggish.
Trade active
August 26, 2024
👉 The Coca-Cola stock has surged above $70 per share, minting day after day new all the history highs (eight ATHs on daily close basis in 2024).
👉 Whatever your trip, drink Coca-Cola.
Trade active
August 29, 2024
👉 The Coca-Cola is one of the most wonderful stocks on U.S. stock markets.
I mean super combo series of consecutive annual growth in a row.
🌟 10 consecutive years of growth in 1960s..
🌟 16 consecutive years of growth in 1980s..
🌟 14 consecutive years of growth in 2010s..
...
...
...
👉 Whoever your trip. Drink Coca-Cola.
Trade active
August 30, 2024
👉 Eleven consecutive months of success.
👉 Whyever your trip, drink Coca-Cola
Trade active
September 3, 2024
👉 The Coca-Cola stock comes closer to major trend (its upper side) near $75, following 7th straight daily gains in a row.
👉 Drink Coca-Cola.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.